{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:16:10Z","timestamp":1780406170100,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.apradiso.2022.110119","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T21:12:21Z","timestamp":1643058741000},"page":"110119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and formulation of [64Cu]Cu-PTSM for PET perfusion imaging in small animal models"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-9678","authenticated-orcid":false,"given":"Mark A.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J.","family":"Mathias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apradiso.2022.110119_bib1","first-page":"697","article-title":"Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu-PTSM","volume":"19","author":"Baerga","year":"1992","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ilar.42.3.248","article-title":"Challenges in small animal noninvasive imaging","volume":"42","author":"Balaban","year":"2001","journal-title":"ILAR J."},{"key":"10.1016\/j.apradiso.2022.110119_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0883-2897(89)90149-9","article-title":"Correlation of Cu(PTSM) localization with regional blood flow in the heart and kidney","volume":"16","author":"Barnhart","year":"1989","journal-title":"Int. J. Radiat. Appl. Instrum. Part B. Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nucmedbio.2009.02.006","article-title":"Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species-dependence and associated substituent effects","volume":"36","author":"Basken","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib5","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/jps.21570","article-title":"Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals","volume":"98","author":"Basken","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.apradiso.2022.110119_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nucmedbio.2007.11.009","article-title":"Species dependence of [64Cu]Cu-Bis(thiosemi- carbazone) radiopharmaceutical binding to serum albumins","volume":"35","author":"Basken","year":"2008","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib7","first-page":"684","article-title":"The kinetics of copper-62-PTSM in the normal human heart","volume":"33","author":"Beanlands","year":"1992","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2967\/jnumed.114.148106","article-title":"Whole-body PET\/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma","volume":"56","author":"Fletcher","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib9","first-page":"91","article-title":"Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging","author":"Fujibayashi","year":"1995","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib10","first-page":"1549","article-title":"Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET","volume":"29","author":"Green","year":"1988","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib11","first-page":"1989","article-title":"[62Cu]-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion","volume":"31","author":"Green","year":"1990","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0883-2897(87)90162-0","article-title":"A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone)","volume":"14","author":"Green","year":"1987","journal-title":"Nucl. Med. Biol. Int. J. Radial. Appl. Instrum. Part B"},{"key":"10.1016\/j.apradiso.2022.110119_bib13","first-page":"1294","article-title":"Assessment of regional myocardial perfusion with generator-produced 62Cu-PTSM and PET in human subjects","volume":"37","author":"Herrero","year":"1996","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.CIR.87.1.173","article-title":"Quantification of regional myocardial perfusion with generator-produced 62Cu-PTSM and positron emission tomography","volume":"87","author":"Herrero","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.apradiso.2022.110119_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2008.07.038","article-title":"Changes in regional brain perfusion during functional brain activation: comparison of [64Cu]-PTSM with [14C]-Iodoantipyrine","volume":"1234","author":"Holschneider","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.apradiso.2022.110119_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0883-2897(89)90163-3","article-title":"Structural characterization of a metal-based perfusion tracer: copper(II) pyruvaldehyde bis(N4-methylthiosemicarbazone)","volume":"16","author":"John","year":"1989","journal-title":"Int. J. Radiat. Appl. Instrum. Part B. Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1021\/jm00168a035","article-title":"Structure-activity relationships for metal-labeled blood flow tracers: comparison of ketoaldehyde bis(thiosemicarbazonato)copper(II) derivatives","volume":"33","author":"John","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.apradiso.2022.110119_bib18","first-page":"228","article-title":"Measurement of local blood flow by the exchange of an inert, diffusible substance","volume":"8","author":"Kety","year":"1960","journal-title":"Methods Med. Res."},{"key":"10.1016\/j.apradiso.2022.110119_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphy.2014.00012","article-title":"Quantitative preclinical PET imaging: opportunities and challenges","volume":"2","author":"Kuntner","year":"2014","journal-title":"Front. Phys."},{"key":"10.1016\/j.apradiso.2022.110119_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nima.2004.03.113","article-title":"Technology challenges in small animal PET imaging","volume":"527","author":"Lecomte","year":"2004","journal-title":"Nucl. Instrum. Methods Phys. Res. Sect. A Accel. Spectrom. Detect. Assoc. Equip."},{"key":"10.1016\/j.apradiso.2022.110119_bib21","first-page":"1451","article-title":"Species-dependent binding of copper(II) bis(thiosemicarbazone) complexes to serum albumin","volume":"36","author":"Mathias","year":"1995","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0969-8051(94)90133-3","article-title":"Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms","volume":"21","author":"Mathias","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib23","first-page":"807","article-title":"Investigation of copper-PTSM as a PET tracer for tumor blood flow","volume":"18","author":"Mathias","year":"1991","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib24","first-page":"351","article-title":"Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM","volume":"31","author":"Mathias","year":"1990","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0969-8051(96)00157-6","article-title":"Efficient production of high specific activity 64Cu using a biomedical cyclotron","volume":"24","author":"McCarthy","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.apradiso.2022.110119_bib26","first-page":"1116","article-title":"Myocardial kinetics of K-38 in humans and comparison with Cu-62-PTSM","volume":"35","author":"Melon","year":"1994","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib27","first-page":"124","article-title":"Structure-function correlations in the reaction of bis(thiosemicarbazone) copper(II) complexes with Ehrlich acites tumor cells","volume":"38","author":"Minkel","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.apradiso.2022.110119_bib28","first-page":"1910","article-title":"Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET","volume":"35","author":"Okazawa","year":"1994","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib29","series-title":"Metal Ions in Biological Systems","first-page":"197","article-title":"Carcinostatic copper complexes","author":"Petering","year":"1980"},{"key":"10.1016\/j.apradiso.2022.110119_bib30","first-page":"367","article-title":"The anti tumor activity of 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone) and related compounds","volume":"24","author":"Petering","year":"1964","journal-title":"Cancer Res."},{"key":"10.1016\/j.apradiso.2022.110119_bib31","first-page":"65","article-title":"Excipient selection in parenteral formulation development","volume":"45","author":"Pramanick","year":"2013","journal-title":"Pharmatimes"},{"key":"10.1016\/j.apradiso.2022.110119_bib32","first-page":"790","article-title":"Brain blood flow measured with intravenous H215O. II. Implementation and validation","volume":"24","author":"Raichle","year":"1983","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0041-008X(72)90032-4","article-title":"Toxicology, metabolism, and biochemistry of 1,2-propanediol","volume":"21","author":"Ruddick","year":"1972","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.apradiso.2022.110119_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.CIR.82.3.990","article-title":"Assessment of regional myocardial and renal blood flow using copper-PTSM and positron emission tomography","volume":"82","author":"Shelton","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.apradiso.2022.110119_bib35","first-page":"1843","article-title":"Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography","volume":"30","author":"Shelton","year":"1989","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/scientificamerican1080-170","article-title":"Positron emission tomography","volume":"243","author":"Ter-Pogossian","year":"1980","journal-title":"Sci. Am."},{"key":"10.1016\/j.apradiso.2022.110119_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00498254.2013.845706","article-title":"Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limits","volume":"44","author":"Thackaberry","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.apradiso.2022.110119_bib38","series-title":"ICH. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)","article-title":"Guidance for industry Q3C impurities: residual solvents","year":"1997"},{"key":"10.1016\/j.apradiso.2022.110119_bib39","series-title":"Food and Drug Administration","article-title":"Q3C \u2014 tables and list guidance for industry. ICH revision 4. U.S. Department of health and human services","year":"2018"},{"key":"10.1016\/j.apradiso.2022.110119_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0006-3061(00)80074-5","article-title":"Comparative properties of the antineoplastic agent 3-ethoxy- 2-oxobutyraldehyde bis(thiosemicarbazone) copper(II) and related chelates: linear free energy relationships","volume":"3","author":"Winkelmann","year":"1974","journal-title":"Bioinorg. Chem."},{"key":"10.1016\/j.apradiso.2022.110119_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2967\/jnmt.111.098632","article-title":"Small-animal PET: what is it, and why do we need it?","volume":"40","author":"Yao","year":"2012","journal-title":"J. Nucl. Med. Technol."},{"issue":"4","key":"10.1016\/j.apradiso.2022.110119_bib42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF00947969","article-title":"Evaluation of copper(II)-pyruvaldehyde bis (N4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model","volume":"21","author":"Young","year":"1994","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2022.110119_bib43","series-title":"Stroke (Fourth Edition) Pathophysiology, Diagnosis, and Management","first-page":"799","article-title":"Chapter 40 - cerebral blood flow and metabolism in human cerebrovascular disease","author":"Zazulia","year":"2004"}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804322000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804322000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:17:49Z","timestamp":1760847469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804322000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":43,"alternative-id":["S0969804322000227"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2022.110119","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and formulation of [64Cu]Cu-PTSM for PET perfusion imaging in small animal models","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2022.110119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110119"}}